Skip to main content
Clinical Trials/EUCTR2021-001801-56-AT
EUCTR2021-001801-56-ATActive, not recruitingPhase 1

Efficacy and Safety of a hyaluronic and lactic acid containing vaginal gel HydroSanta® Vaginalgel” for the treatment of vaginal dryness symptoms – a multicenter randomized two-arm study

Gynial GmbH0 sites90 target enrollmentStarted: August 30, 2021Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • Informed consent
  • Biological sex: female (women only)
  • Women with moderate or severe vaginal dryness
  • Age > 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Currently under vaginal atrophy treatment
  • Vaginal infections such as trichomonas, candida, and bacterial vaginosis (BV)
  • Patients with breast cancer, uterine cancer or estrogen hormone-dependent tumors, and genital bleeding of unknown origin
  • Known allergy against ingredients of the study intervention (e.g. estriol)

Investigators

Sponsor
Gynial GmbH

Similar Trials